Author
Listed:
- Masahiro Yoshida
(Jikei University School of Medicine)
- Shunsuke Minagawa
(Jikei University School of Medicine)
- Jun Araya
(Jikei University School of Medicine)
- Taro Sakamoto
(Kitasato University)
- Hiromichi Hara
(Jikei University School of Medicine)
- Kazuya Tsubouchi
(Jikei University School of Medicine)
- Yusuke Hosaka
(Jikei University School of Medicine)
- Akihiro Ichikawa
(Jikei University School of Medicine)
- Nayuta Saito
(Jikei University School of Medicine)
- Tsukasa Kadota
(Jikei University School of Medicine)
- Nahoko Sato
(Jikei University School of Medicine)
- Yusuke Kurita
(Jikei University School of Medicine)
- Kenji Kobayashi
(Jikei University School of Medicine)
- Saburo Ito
(Jikei University School of Medicine)
- Hirohumi Utsumi
(Jikei University School of Medicine)
- Hiroshi Wakui
(Jikei University School of Medicine)
- Takanori Numata
(Jikei University School of Medicine)
- Yumi Kaneko
(Jikei University School of Medicine)
- Shohei Mori
(Jikei University School of Medicine)
- Hisatoshi Asano
(Jikei University School of Medicine)
- Makoto Yamashita
(Jikei University School of Medicine)
- Makoto Odaka
(Jikei University School of Medicine)
- Toshiaki Morikawa
(Jikei University School of Medicine)
- Katsutoshi Nakayama
(Jikei University School of Medicine)
- Takeo Iwamoto
(Jikei University School of Medicine)
- Hirotaka Imai
(Kitasato University)
- Kazuyoshi Kuwano
(Jikei University School of Medicine)
Abstract
Ferroptosis is a necrotic form of regulated cell death (RCD) mediated by phospholipid peroxidation in association with free iron-mediated Fenton reactions. Disrupted iron homeostasis resulting in excessive oxidative stress has been implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). Here, we demonstrate the involvement of ferroptosis in COPD pathogenesis. Our in vivo and in vitro models show labile iron accumulation and enhanced lipid peroxidation with concomitant non-apoptotic cell death during cigarette smoke (CS) exposure, which are negatively regulated by GPx4 activity. Treatment with deferoxamine and ferrostatin-1, in addition to GPx4 knockdown, illuminate the role of ferroptosis in CS-treated lung epithelial cells. NCOA4-mediated ferritin selective autophagy (ferritinophagy) is initiated during ferritin degradation in response to CS treatment. CS exposure models, using both GPx4-deficient and overexpressing mice, clarify the pivotal role of GPx4-regulated cell death during COPD. These findings support a role for cigarette smoke-induced ferroptosis in the pathogenesis of COPD.
Suggested Citation
Masahiro Yoshida & Shunsuke Minagawa & Jun Araya & Taro Sakamoto & Hiromichi Hara & Kazuya Tsubouchi & Yusuke Hosaka & Akihiro Ichikawa & Nayuta Saito & Tsukasa Kadota & Nahoko Sato & Yusuke Kurita & , 2019.
"Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis,"
Nature Communications, Nature, vol. 10(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10991-7
DOI: 10.1038/s41467-019-10991-7
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Fabian Hoelzgen & Thuy T. P. Nguyen & Elina Klukin & Mohamed Boumaiza & Ayush K. Srivastava & Elizabeth Y. Kim & Ran Zalk & Anat Shahar & Sagit Cohen-Schwartz & Esther G. Meyron-Holtz & Fadi Bou-Abdal, 2024.
"Structural basis for the intracellular regulation of ferritin degradation,"
Nature Communications, Nature, vol. 15(1), pages 1-10, December.
- Julie Routhier & Stéphanie Pons & Mohamed Lamine Freidja & Véronique Dalstein & Jérôme Cutrona & Antoine Jonquet & Nathalie Lalun & Jean-Claude Mérol & Mark Lathrop & Jerry A. Stitzel & Gwenola Kervoa, 2021.
"An innate contribution of human nicotinic receptor polymorphisms to COPD-like lesions,"
Nature Communications, Nature, vol. 12(1), pages 1-13, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10991-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.